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Locus control regions (LCRs) are defined by their ability to confer reproducible physiological levels of transgene expression in mice and
therefore thought to possess the ability to generate dominantly a transcriptionally active chromatin structure. We report the first characterization of
a muscle-cell-specific LCR, which is linked to the human desmin gene (DES). The DES LCR consists of five regions of muscle-specific DNase I
hypersensitivity (HS) localized between −9 and −18 kb 5′ of DES and reproducibly drives full physiological levels of expression in all muscle cell
types. The DES LCR DNase I HS regions are highly conserved between humans and other mammals and can potentially bind a broad range of
muscle-specific and ubiquitous transcription factors. Bioinformatics and direct molecular analysis show that the DES locus consists of three
muscle-specific (DES) or muscle preferentially expressed genes (APEG1 and SPEG, the human orthologue of murine striated-muscle-specific
serine/threonine protein kinase, Speg). The DES LCR may therefore regulate expression of SPEG and APEG1 as well as DES.
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eukaryotes has revealed that chromosomal gene order in these
organisms is not random; genes that have similar functions or
whose expression needs to be tightly coordinated are generally
clustered [1]. This observation adds support to the concept that
genes in higher eukaryotes are organized in the form of func-
tional domains [2] or functional expression modules [3], with
each domain possessing genetic control elements or undergoing
processes that are able to establish and maintain a transcription-
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doi:10.1016/j.ygeno.2006.01.009or ubiquitous gene expression. A major challenge of the
postgenomic era is the elucidation of the mechanisms by
which a transcriptionally competent open chromatin domain is
established and how spatial and temporal patterns of expression
are coordinated from within arrays of genes. At present there are
only two known classes of transcriptional regulatory elements
that appear to be part of dominant chromatin remodeling
processes and that may also be involved in coordinating gene
expression, namely locus control regions (LCRs) [4] and CpG
islands associated with housekeeping genes [5].
LCRs are functionally defined by their ability to confer on a
transgene linked in cis reproducible physiological levels of
expression regardless of integration site [4]. The involvement of
LCRs in processes that establish a dominant, transcriptionally
competent open chromatin structure at ectopic transgene
integration sites is most clearly demonstrated by their ability
Fig. 1. A cosmid clone encompassing DES with 22 kb of 5′ flanking sequences
gives reproducible, full physiological levels of expression in transgenic mice.
(A) Illustration of the cosmid clones 22DES and 4.6DES with 22 and 4.6 kb of
5′ flanking sequences, respectively, and encompassing the complete DES gene.
Horizontal arrows denote the direction of transcription. (B) The genomic inserts
in 22DES (39.92 kb) and 4.6DES (35.76 kb) were isolated and used to generate
transgenic mice. Southern blot analysis was used to determine transgene copy
number and integrity (data not shown). Transgenic founder mice 22DES-23,
-B1, and -A4 and 4.6DES-D0 and -D1 were successfully bred through to
established lines. Total RNA was isolated from a range of muscle (bladder,
uterus, leg muscle, heart) and nonmuscle (liver, kidney, spleen, lung) tissues
from three F1 or F2 generation animals per established line that were at least
2 months of age. RNA from the same range of tissues was also prepared from the
4.6DES transgenic founder mice (A0, A1) that did not breed through to the F1
stage. These RNA samples were analyzed for transgene expression by an S1-
nuclease protection assay and results calculated as the average level of
expression of human DES as a percentage of endogenous mouse desmin per
transgene copy (see Materials and methods). The results from the smooth muscle
uterine and bladder, skeletal leg muscle, and heart muscle are shown. No
expression was detected in nonmuscle tissues (data not shown). Numbers in
parentheses denote transgene copy number and F represents founder transgenic
mice that did not breed through to established lines. Reproducible, physiological
levels of expression per transgene copy are seen in all muscle cell types with
22DES but not 4.6DES.
734 J.L.Y. Tam et al. / Genomics 87 (2006) 733–746to drive physiological and stable levels of expression even from
within or near centromeres, showing they can obstruct the
spread of heterochromatin and prevent progressive silencing
that leads to a variegated expression pattern [6]. LCRs appear to
participate in two activities in the regulation of gene expression:
the establishment of a transcriptionally competent chromatin
structure and a dominant transcriptional activation capacity to
confer reproducible physiological levels of expression per
transgene copy [2–4]. It has also recently been established that
LCRs activate and coordinate transcription by coming into close
proximity to the gene that is required to be expressed via a
DNA/chromatin looping mechanism [3].
There are still relatively few transcriptional regulatory elements
that have been described that strictly meet the criteria of LCR
activity. However, bone fide LCRs have invariably been found
linked with tissue-specific genes and to consist of a series of
elements sensitive to digestion with DNase I [DNase I-hypersen-
sitive (HS) sites] and located either 5′ or 3′ of the gene or genes that
they regulate. LCRs located in a 5′ position are theβ-globin family
[3], chicken lysozyme [7], the human red and green visual pigment
[8], the murine MHC Class II Ea gene (Ea1) [9], mouse tyrosinase
(Tyr) [10], the human growth hormone (GH1)–chorionic somato-
mammotropin (CSHL1) gene cluster, which shows a dual pituitary
and placental specificity [11], and possibly the human serpin gene
cluster [12]. Most recently described is the LCR that regulates Th2
cell expression of the IL4 and IL13 cytokine genes [13]; this
element is located within the RAD50 gene, which lies between IL5
and IL13. LCRs that are present 3′ of their cognate genes are
humanCD2 [14], human IgH [15,16], human apolipoprotein E/C-I
[17], and the murine α/δ T cell receptor (Tcra/Tcrd)–defender
against cell death 1 (Dad1) locus [18]. The LCR activity associated
with the mouse λ5–light chain (Igl-C5) locus appears to be
distributed both 5′ and 3′ of this gene [19].
Our functional analysis in transgenic mice of a 240-kb
genomic clone (240DES) encompassing the human desmin
gene (DES), with 220-kb 5′ and 10-kb 3′ flanking sequences, is
the only report to date showing definitive data demonstrating
the existence of muscle-specific LCR activity [20]. We have
now extended these initial studies and show that the LCR
associated with the DES locus (DES LCR) is a complex,
multiple-component element located within 18 kb 5′ of the DES
transcriptional start site and is highly conserved between human
and other mammalian (rodent, canine, opossum) species. We
also show that the DES locus consists of three genes, namely
DES, AY603755 (SPEG; the human orthologue of the murine
striated muscle-specific serine/threonine protein kinase gene,
Speg), and aortic preferentially expressed gene 1 (APEG1),
suggesting that the DES LCR forms a key part of a functional
expression module [3] that may be involved in regulating
expression of SPEG and APEG1 as well as DES.
Results
The 5′ DES region possesses LCR activity
Our previous analysis of PAC clone 240DES in mice showed
that line DN55, harboring a single copy of this transgene,possessed a deletion that removed almost the entire 3′ flanking
sequences past the poly(A)-addition site [20]. However, this
deleted transgene was still fully functional with respect to DES
expression, indicating that the DES transcriptional regulatory
elements including any LCR are in all likelihood located 5′ of
the transcriptional start site.
To test this possibility functionally we isolated cosmid
clones spanning DES with either 22 kb (22DES; Fig. 1A) or
4.6 kb (4.6DES; Fig. 1A) of 5′ flanking sequences. These two
cosmid clones were then used to generate transgenic mice. A
total of three transgenic lines were obtained with 22DES,
Southern blot analysis of which showed transgene copy
numbers of 2, 4, and 5 (data not shown). The copy number of
the four transgenic mice harboring 4.6DES ranged from 2 to 28
(data not shown) although only two mice (D0 and D1) were
successfully bred on to establish lines. Total RNA was isolated
from a range of muscle and nonmuscle tissues from three F1 or
F2 generation animals per established line that were at least
735J.L.Y. Tam et al. / Genomics 87 (2006) 733–7462 months of age. RNA from the same range of tissues was also
prepared from the 4.6DES transgenic founder mice (A0, A1)
that did not breed through to the F1 stage. These RNA samples
were analyzed by an S1-nuclease protection assay and results
calculated as the average expression of human DES as a
percentage of endogenous mouse desmin mRNA per transgene
copy as previously described [20].
The results show that 22DES gave rise to consistent, full
physiological levels ofDES expression per transgene copy in all
muscle tissues analyzed (Fig. 1B, left). Expression in the
smooth muscle bladder and uterine samples respectively ranged
from 145 to 210% and from 144 to 175% of endogenous mouse
desmin per transgene copy, whereas in cardiac muscle
expression was 319–373%. Skeletal leg muscle showed
expression of 141 and 179% in lines 23 and B1, respectively.
However, a large positive position effect was evident in line A4,
which showed an average expression of 308% per transgene
copy in this tissue. Human DES transgene expression was not
observed in nonmuscle tissues such as liver, spleen, kidney, and
lung (data not shown). In marked contrast expression of the
DES transgene from 4.6DES was significantly lower in all
muscle cell types analyzed (Fig. 1B, right). Expression in the
uterine and bladder smooth muscle samples was 2–10%, in
cardiac muscle 31–130%, and in skeletal leg muscle 10–22% of
murine desmin per transgene copy. Further analysis of
transgenic mice harboring a DES genomic clone deleted to
−1.7 kb from the transcriptional start site gave a pattern of
expression similar to that seen with 4.6DES (data not shown).
These data show that 22DES but not 4.6DES expresses with the
same efficiency and specificity as the 240-kb PAC clone
encompassing the human desmin gene that we had previously
shown to possess LCR activity [20]. Taken together these
results strongly suggest not only that 22DES contains an LCR
but also that the region located between −4.6 and −22 kb 5′ of
the DES transcriptional start site is essential for this function.
Muscle-specific DNase I hypersensitive sites are located 5′
of DES
All LCRs identified to date have been found to consist of a
series of tissue-specific DNase I HS sites [4]. As the transgenic
mouse expression data with the 22DES and 4.6DES cosmid
clones indicated the presence of LCR-type elements between
−4.6 and −22 kb from the DES Cap site (Fig. 1), we next
undertook experiments to determine if muscle-specific DNase I
HS sites are located within this 5′ region.
Sufficient quantities of pure skeletal myoblasts to carry out
this analysis were obtained by crossing a homozygous fully
functional single-copy 240DES transgenic mouse line (DN28)
[20] with homozygous ImmortoMouse animals [21]. As the
ImmortoMouse contains a gene for temperature-sensitive SV40
large T-antigen (tsA58), this allowed the isolation from these
double-transgenic animals clones of myoblast cells with a
highly extended life span in tissue culture when grown at the
permissive temperature of 33°C [22]. Transgenic myoblast
cultures were allowed to grow to confluency and transferred to
nonmitogenic medium to stimulate differentiation (fusion) tomyotubes to induce DES transgene expression. Nuclei isolated
from these myotubes were then subjected to DNase I HS site
analysis as previously described [23,24]. The presence of
DNase I HS sites was investigated within a conveniently located
XhoI restriction enzyme fragment extending from −1.7 to
−18.6 kb from the start of DES transcription (Fig. 2D). This
region extends from immediately upstream of the known
skeletal muscle-specific promoter and enhancer elements [25].
Southern blot analysis employed probes from the 5′ and 3′ ends
of the XhoI fragment (Fig. 2D).
In the 5′ direction from the start ofDES transcription, a series
of HS sites are clearly discernable as bands of 7.8 kb, 9.7 kb,
11.1/11.3-kb doublet, and 13.6 kb when using the 3′ PstI probe
(Fig. 2B). Analysis with the 5′ XhoI–SacI probe gives a weak
but discernable band of 8.3 kb and more prominent fragments of
7.1, 5.4, 4.9, and 1.7 kb (Fig. 2A). There is a good correlation
between the location of HS sites of 7.8, 9.7, 11.1, and 11.3 kb
seen with the 3′ probe respectively with those of 8.3, 7.1, 5.4,
and 4.9 kb upon hybridization with the 5′ probe. The bands of
13.6 (Fig. 2B) and 1.7 kb (Fig. 2A) are detected only with their
respective probes. These data taken together demonstrate the
presence of DNase I HS sites at positions −9.5 kb (HS1),
−11.4 kb (HS2), −13.2 kb (HS3i), −13.7 kb (HS3ii), −15.3 kb
(HS4), and −16.9 kb (HS5) from the DES transcriptional start
site (Fig. 2D, HS1–5).
Similar experiments with the nonmuscle human myeloge-
nous leukemia cell line K562 [26] showed the absence of any
DNase I HS sites within the 16.9-kb XhoI region, indicating that
HS sites 1–5 are muscle specific (Fig. 2C). This suggests that
the regions of DNase I hypersensitivity we have identified 5′ of
DES may highlight the location of transcriptional regulatory
elements and may at least in part constitute an LCR.
The DES locus consists of three closely linked muscle
preferentially expressed genes
As LCRs are implicated as playing a major role in
coordinating expression from within gene clusters [2–4], we
placed the location of the upstream DNase I HS site regions that
may constitute the DES LCR within the context of the locus as a
whole. The Human Genome Browser Gateway (http://zeon.
well.ox.ac.uk/cgi-bin/hgGateway?org=Human&db=hg12&
hgsid=61887), NCBI Map Viewer (http://www.ncbi.nlm.nih.
gov/mapview/map_search.cgi?taxid=9606), and Ensembl Ge-
nome Browser (http://www.ensembl.org/Homo_sapiens/index.
html) databases show a number of genes within the immediate
vicinity of DES. Specifically, they show that 30.5 kb 5′ of DES
is the transcriptional start site of aspartyl aminopeptidase
(DNPEP), a housekeeping gene [27]. The 5′ end of a gene
designated as aortic preferentially expressed gene 1 (APEG1)
[28] is located 16.9 kb 3′ of DES. Another housekeeping gene,
GDP mannose pyrophosphorylase (GMPPA) is positioned
32 kb 3′ of APEG1. In addition, the Ensembl Genome Browser
shows there are a further two gene sequences that lie between
APEG1 and GMPPA; Q9P2P9 (ENSG00000072195), 26.4 kb
in length, which is indicated as encoding a fragment of “striated
muscle preferentially expressed protein,” and a novel Ensembl
Fig. 2. Muscle-specific DNase I hypersensitive sites are located 5′ of the DES promoter region. DNase I HS site mapping was conducted within the 5′ region of DES to
locate potential transcriptional regulatory elements that may constitute at least in part an LCR. Cultures of skeletal myoblast cell clones from double-transgenic mice
homozygous for a single-copy integration of a fully functional 240-kb PAC clone spanning the DES locus (line 240DES-DN28) [20] and homozygous for a
temperature-sensitive large SV40 T-antigen tsA58 gene (ImmortoMouse) [21,22] were induced to undergo fusion to myotubes, and nuclei were isolated and subjected
to DNase I HS site mapping (see Materials and methods). Genomic DNA from DNase I-treated nuclei was digested with XhoI and Southern blotted. The presence of
DNase I HS sites was assessed within a 16.9-kb region extending from −1.7 to −18.6 kb from theDES transcriptional start site. Blots were sequentially probed with (A)
a 5′ 626-bp XhoI–SacI fragment (position −18.6 to −17.974 kb) and (B) a 3′ 940-bp PstI fragment (position −2163 to −3103 bp). Arrowheads mark the position and
size in kilobases of the parental 16.9-kb XhoI fragment and subfragments resulting from digestion at DNase I HS sites. The horizontal arrow above the lanes denotes
increasing amount of DNase I, with the sample in the first lane receiving no enzyme. (C) The same DNase I HS site mapping procedure applied to nuclei isolated from
the human myelogenous leukemia cell line K562, which acted as a nonmuscle negative control. M, 1 kb ladder size markers. (D) Illustration of the 5′ region of DES
showing the positions of DNase I HS sites (HS1–5; vertical arrows) identified in panels A and B and their distance in kilobases from the DES transcriptional start site.
The positions of the XhoI sites at −1.7 and −18.6 kb and the position of the 5′ XhoI/SacI and 3′ PstI probes (black rectangles) within the 16.9-kb XhoI region used in
Southern blots A and B, respectively, are also shown. The arrowhead denotes the direction of DES transcription.
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homology to the myosin light chain kinase family.
This gene organization at the DES locus is similar to that
seen in the equivalent position in mouse (Figs. 3B, H; data not
shown) except for the annotation with respect to APEG1. In the
mouse, the Human Genome Browser Gateway and Ensembl
Genome Browser show Apeg1 as a gene of 57 kb with its 5′ end
7.6 kb 3′ of Des and its 3′ end 3.6 kb 5′ of Gmppa. This
contrasts with the indicated extent of APEG1, which is shown as
being only 23.2 kb in length starting 16.9 kb 3′ of DES and
terminating 32 kb 5′ of GMPPA.
This difference in the extent of the APEG1 and Apeg1
transcription units prompted us to conduct a detailed compar-
ative sequence analysis of this region. First, we analyzed BAC
clone AC053503 with the Nucleotide Identification (NIX)
program of the former UK Medical Research Council Human
Genome Mapping Project (HGMP) facilities using Genescan
[now available through Ensembl (http://www.ensembl.org/)]
and the former Celera public database. These programs
predicted the presence of a 62.1-kb gene starting approximately
8.3 kb downstream of DES and from which the partial cDNAclone KIAA1297 (Accession No. AB037718) of the Kazusa
cDNA sequencing project [29] appears to be derived (Fig. 3A;
data not shown). This is homologous to what is present in the
mouse and other mammals (Fig. 3B). In addition, we found by
BLAST analysis (http://www.ncbi.nlm.nih.gov/BLAST/) of
AB037718 that this mRNA corresponds to the human
orthologue of the murine striated muscle preferentially
expressed protein gene (Speg; Accession Nos. AF215896 and
AAG34791), which like APEG1 is a serine/threonine protein
kinase [30]. In addition, a compilation of cDNA sequences that
extends AB037718 in the 5′ direction by 2.5 kb (AY603755)
and that is designated as human striated muscle preferentially
expressed protein (SPEG) mRNA has been reported [31].
Although there have been extensive experimental analyses of
the murine Apeg1 [28] and Speg [30] genes and their transcripts,
none has as yet been reported on the corresponding human
locus. We therefore conducted multiple muscle-tissue Northern
blot analysis to determine whether AY603755 displays a
preferential striated (skeletal and cardiac) muscle expression
pattern, which would confirm and add further evidence that it is
the human orthologue of Speg. Based on published data on the
Fig. 3. Gene order at the DES locus and the DNA sequence underlying the muscle-specific DNase I HS sites 5′ of DES is highly conserved between human and
mammalian species. (A) Illustration of the gene organization at the DES locus ascertained by bioinformatics and direct molecular analysis (see Materials and methods;
Fig. 4). Large shaded rectangles denote identified genes;DNPEP, aspartyl aminopeptidase;DES, desmin; APEG1, aortic preferentially expressed gene 1 [28];GMPPA,
GDP mannose pyrophosphorylase; SPEG, human orthologue of murine striated muscle-specific serine/threonine protein kinase (Speg) [30]. 5′ DNase I HSS, region
encompassing the muscle-specific DNase I HS sites (Fig. 2) that constitute the DES LCR. (B) Multiple vertebrate genome comparison of the DES locus employing the
ECR Browser. The conservation profiles of the human DES locus region in comparison with the zebrafish (A, Zeb), Fugu (B, Fug), tetraodon fish (C, Tet), frog (D,
Fro), chicken (E, Chi), opossum (F, Opo), rat (G, Rat), mouse (H, Mou), and dog (I, Dog) genomes are shown. Plots were constructed by using a sliding window of
30 bp throughout the alignment with a minimum identity of 80%. A conserved alignment is shown in blue if it overlaps with a coding exon; yellow, untranslated exon
region; pink, intron; red, intergenic region. Red bars at the top of each layer of sequence comparison provide an overview of the distribution of evolutionarily
conserved regions and are used to highlight underlying regions of alignment. Green bars at the base of each layer indicate the locations of repetitive elements. The
positions of the various genes within the DES locus (A) as well as the 5′ DNase I hypersensitive sites (5′ DNase I HSS; see Fig. 2) that potentially constitutes the DES
LCR are indicated. Note: SPEG is currently not highlighted within the database but is shown as conserved intergenic sequences.
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Celera public database (data not shown), AY603755 lacks the
sequence of the first 358-bp exon (Accession No. DQ395348;
see Supplementary Fig. 1). This additional 5′ exon places the
start of the transcription unit within which AY603755 is
contained 8.3 kb 3′ of DES rather than 16.9 kb as indicated in
the current database (Fig. 3A). We therefore decided to
hybridize the Northern blot with a probe corresponding to the
putative missing first exon of AY603755 (see Materials and
methods) to confirm its authenticity. The results show that,
again as can be deduced from the murine situation [30], multiple
RNA isoforms are detected with this probe (Fig. 4). However,
an approximately 11-kb mRNA was detected only in skeletal
muscle and, to a lesser degree, in cardiac tissue and appears to
correspond to Spegβ [30]. A predominant novel mRNA of
about 5 kb is expressed at markedly higher levels in skeletal leg
and cardiac muscles. This confirms the striated muscle
preferentially expressed nature of AY603755 and therefore in
all likelihood does correspond to the human equivalent of Speg
[30,31].
Murine Apeg1 was originally reported as a 4.5-kb gene with
a preferential aortic vascular smooth muscle expression pattern
[28]. Apeg1 was subsequently shown to be present within and
constitute one isoform of a much larger transcription unit that
also encodes the striated muscle preferentially expressed
proteins SPEGα and β as well as the brain isoform BPEG[30]. Our comparative sequence analysis (Fig. 3B; data not
shown) shows that the human equivalent of Apeg1 is 5.5 kb in
length and is similarly contained within the larger transcription
unit encoding the human SPEG protein and from which
AY603755 is derived. Consequently, this places the 5′ end of
APEG1 26.4 kb downstream of the predicted SPEG gene
transcriptional start site (Fig. 3A). Furthermore, the entire
AB037718 cDNA corresponds to the Q9P2P9 gene and
Q9P2P9 as well as AY603755 may lack additional 3′ sequences
contained within the Ensembl Genome Browser predicted gene
fragment ENSG00000144585. As a result both Q9P2P9 and
AY603755 sequences are indicated in the current database to
terminate 5.3 kb from the GMPPA start site instead of 1.1 kb
(Figs. 3A and 3B). Collectively, these data show that the
DES locus consists of a functional chromatin cluster of three
closely linked, muscle-specific (DES) or muscle preferentially
expressed (SPEG; APEG1) genes within a 79-kb interval
(Fig. 3A).
Gene order and the 5′ DNase I HS site regions at the DES
locus are highly conserved across mammalian species
We conducted comparative genome analysis between human
and other species using the ECR Browser (http://ecrbrowser.
dcode.org/) [32]. This demonstrated that order, relative position,
and transcriptional direction of genes, as well as the 5′ DNase I
Fig. 4. Confirmation of the AY603755 cDNA, murine Speg orthologous
transcription unit 3′ of DES. A commercially available Northern blot of poly
(A)+-RNA samples from various human muscle tissues was probed with a PCR-
generated 400-bp unique sequence DNA fragment spanning a predicted first
exon (Fig. 3B; see Supplementary Fig. 1) located 5′ of the human SPEG
compilation sequence AY603755 and 8.3 kb downstream of DES (see Materials
and methods). This probe highlights the presence of different mRNA isoforms
starting from this position. A major 5-kb species is present at markedly elevated
levels within skeletal and cardiac tissues. The largest, 11-kb RNA also shows a
striated (skeletal, cardiac) muscle-specific expression pattern. Arrows denote the
approximate sizes of the main isoforms.
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in the rat (Figs. 3B, G), mouse (Figs. 3B, H), and dog (Figs. 3B,
I) genomes. Gene type and order at the desmin locus are also
conserved between humans/mammals and the North American
opossum marsupial (Figs. 3B, F). However, the regions of the 5′
DNase I HS sites are less well conserved in the opossum, with
only components corresponding to HS1 and HS3 as well as a
short element 5′ of HS5 (Fig. 2) showing homology above the
50% threshold of analysis (Figs. 3B, F; see Supplementary Fig.
2). Although the relative positions of DES and DNPEP are
preserved between human and chicken, frog, Fugu, zebrafish,
and tetraodon fish (Figs. 3B, A–E), these loci also show a
number of striking comparative differences, with the region
corresponding to the 5′ half of the SPEG gene and APEG1 as
well as the 5′ DNase I HS site regions being absent (Figs. 3B,
A–E). In addition, the GMPPA gene appears to be absent from
the 3′ end of the locus in chicken, Fugu, and zebrafish (Figs.
3B, A, B, and E).
The conserved sequence within the 5′ DNase I HS site regions
Comparative genomic DNA sequence analysis across
species has been successfully used to highlight known and
potential transcriptional regulatory elements [33–36]. We
therefore performed a detailed human–rodent comparative
sequence analysis of the 5′ DES region using a number of
programs to confirm the identity of regions of homology and
determine their precise sequence. As the sequence of BAC
clones spanning the desmin locus in human (AC053503),mouse (AC114651), and rat (AC121633) is available, regions
up to 20 kb upstream of the transcriptional start site were
initially used for dot-plot analysis employing the Jemboss
software package provided by the former UKMedical Research
Council HGMP facilities. Regions of homology between both
human and mouse and human and rat were obtained within the
area immediately 5′ of the desmin gene, which included the
previously identified promoter as well as skeletal [25,37] and
vascular smooth [38] muscle enhancer elements. The only other
regions of homology identified by this analysis were short
stretches of sequence distributed between approximately −9 and
−18 kb from the DES transcriptional start site, again in both
human–mouse and human–rat comparisons (data not shown).
To improve the resolution and confirm the results obtained
by dot-plot analysis, a sequence comparison was then
undertaken using the mVISTA program (http://www-gsd.lbl.
gov/vista/) with a window size set at 50 bp and a high homology
threshold of 75%. A comparison of the human and mouse
sequences showed peaks of homology not only as expected at
the exon and promoter regions (data not shown), but also
between −9 and −18 kb from the DES Cap site (Fig. 5B).
Furthermore, there is a good correlation between the peaks of
human–mouse homology and the position of the muscle-
specific DNase I HS sites (Fig. 5B, vertical arrows), with the
slight exception of HS5, which in all likelihood reflects a lack in
the resolution of the Southern blot analysis (Fig. 2). Similar
results were obtained with a comparison of human and rat
sequences (Fig. 3B and data not shown).
We next determined precisely the regions of human–rodent
homology that underlie the muscle-specific DNase I HS sites,
by a DNA sequence comparison of the same 20-kb upstream
regions employing BLAST followed by CLUSTALW (http://
www.ebi.ac.uk/clustalw/) to obtain a multisequence alignment.
Within the area −9 to −18 kb we found 12 elements of high (83–
100%) human–rodent homology ranging in size from 32 to
411 bp (Fig. 6), which precisely correspond to the peaks of
homology revealed by the mVISTA analysis (Fig. 5C).
The 5′ DES regions of high human–rodent homology are areas
with the potential to bind a high density of transcription factors
specific for all muscle cell types
All DNase I HS site elements that constitute LCRs and that
have been analyzed to date consist of clusters of tissue-specific
and ubiquitous transcription factor binding sites [4]. To obtain
initial insight into the complement of factors that may bind to,
and mediate the function of, the human–rodent regions of
homology (Figs. 5 and 6) corresponding to the muscle-specific
HS sites 5′ of DES and that may constitute the DES LCR (Fig.
1), we scrutinized the sequence of these elements for potential
transcription factor binding sites that have been demonstrated to
regulate muscle-specific gene expression [39] using a number
of prediction programs (rVISTA, ConSite, TFSEARCH,
PATCH; see Materials and methods).
These programs do indeed predict the presence of both
tissue-specific and ubiquitous transcription factor binding sites
on both forward (+) and reverse (−) strands of the DNA that are
Fig. 5. Bioinformatics analysis of the DNA sequence underlying the muscle-specific DNase I HS sites of 5′ DES (Fig. 2) reveals 12 elements that are highly conserved
between human and rodent species. (A) Illustration of the relative positions ofDES and the muscle-specific 5′DNase I HS sites (HSS) that constitute theDES LCR (see
Figs. 2 and 3). (B) The region starting from within exon I and extending for 20 kb 5′ of the desmin gene transcriptional start site was obtained from human (AC053503)
and mouse (AC114651) BAC clones and subjected to a comparative DNA sequence analysis using the mVISTA program employing a window size set at 50 bp and a
high homology threshold of 75%. Peaks highlighting elements with a minimum 75% homology were observed not only as expected within the promoter region (data
not shown), but also in the region between −9 and −18 kb from theDES transcriptional start site and which corresponded to the positions of the muscle-specific DNase
I HS sites (HS1–HS5, vertical arrows; see Fig. 2). Very similar results were obtained with a human–rat comparative analysis (data not shown). (C) Illustration of the
positions of the 12 elements of human–mouse (Mo) and human–rat (Ra) homology obtained by BLAST followed by CLUSTALW comparative sequence analysis
(Fig. 6) between −9 and −18 kb from the DES transcriptional start. The 12 elements are grouped into five locations that correspond to the peaks of homology obtained
by mVISTA and the areas occupied by the muscle-specific DNase I HS sites. The elements of human–rodent homology are therefore named by reference to the DNase
I HS site with which they are associated. Numbers indicate distances in kilobases from the DES start of transcription.
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Supplementary Fig. 3) and that have been shown to regulate
gene expression in skeletal, cardiac, and smooth muscle both
during development and in adult life [39].
The 5′ DES DNase I HS site human–rodent homology regions
are sufficient for reproducible, physiological levels of
muscle-specific expression in transgenic mice
The functional expression data in mice with the 22DES and
4.6DES cosmid clones (Fig. 1) in combination with the DNase I
HS site mapping (Fig. 2) and DNA sequence analysis (Figs. 3,
5, and 6) strongly suggest that the region between −9 and
−18 kb 5′ of the DES Cap site is a potent muscle-specific
transcriptional regulatory element that may have an LCR
capability. To confirm that this region alone is sufficient to
confer LCR function and that no elements are present either
within or downstream of DES, we asked whether these DES 5′
flanking sequences could confer reproducible, high levels of
expression upon a heterologous reporter gene. A construct
extending from −18.6 to +30 bp from the DES transcriptional
start site, which includes all the DNase I HS site/human–rodent
homology regions, and linked to a human β-globin (HBB)
reporter gene (18.6DESβ; Fig. 7A), was functionally analyzedin transgenic mice. A total of six transgenic lines harboring
18.6DESβ were obtained and ascertained by Southern blot
analysis (data not shown) to range in transgene copy number
from 3 to 11. Expression analysis in three mice per transgenic
mouse line harboring this construct was conducted using an S1-
nuclease protection assay, simultaneously probing for the 3′ end
of the HBB reporter mRNA [40] and endogenous murine
desmin mRNA [20]. HBB mRNA levels were calculated as a
percentage of murine desmin on a transgene copy number basis
as in the case of the 22DES and 4.6DES mice (Fig. 1B).
Unlike in the case of transgenic animals harboring 22DES
and 4.6DES (Fig. 1), it is not possible to obtain an absolute
measure of 18.6DESβ expression efficiency in relation to the
endogenous murine Des internal reference since, in all
likelihood, the mRNAs derived from these two genes will
differ in their relative stabilities in the various muscle tissues
analyzed. However, all transgenic lines gave rise to high levels
of HBB reporter gene expression in all muscle cell types
analyzed, with the same degree of reproducibility per transgene
copy as that obtained with the 22DES genomic clone (Fig. 7B).
Expression in the smooth muscle bladder and uterine compart-
ments was 73–140 and 56–130%, respectively; in cardiac
muscle 95–177%; and in skeletal leg muscle 46–136% of
endogenous mouse desmin mRNA per transgene copy. As in the
Fig. 6. The sequence of the human–rodent (mouse, rat) regions of homology that underlie the muscle-specific DNase I HS sites. The 20-kb regions 5′ of the DES
transcriptional start site were obtained from human (AC053503), mouse (AC114651), and rat (AC121633) BAC clones. These were subjected sequentially to a DNA
sequence comparison employing BLAST followed by CLUSTALW to obtain a multisequence alignment. Within the area −9 to −18 kb a total of 12 elements that are
highly conserved (83–100% homology) between humans and rodents (Mus; Rat) ranging in size from 32 to 411 bp were identified and correspond to the regions of the
muscle-specific DNase I HS sites (Figs. 5B and 5C). Stars denote nucleotides that are conserved between all three species.
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Fig. 7. The 5′ DES region is sufficient to confer reproducible, physiological
levels of expression in transgenic mice. (A) Illustration of the 18.6DESβ
construct that links the 5′ region of DES extending from −18.6 to +30 bp from
the transcriptional start site (horizontal arrow) to a human β-globin (HBB)
reporter gene starting at +20 bp. The positions of the muscle-specific DNase I
HS sites (Fig. 2) encompassing the elements that are highly conserved between
humans and other mammals (Figs. 3, 5, and 6) are indicated (vertical arrows).
(B) 18.6DESβwas used to generate six lines of transgenic mice. Transgene copy
number and integrity were determined by Southern blot analysis (data not
shown). Expression analysis in three mice per transgenic mouse line harboring
this construct was conducted using total RNA and an S1-nuclease protection
assay in a range of muscle (bladder, uterus, heart, leg muscle) and nonmuscle
(liver, kidney, spleen, lung) tissues, simultaneously probing for the 3′ end of the
HBB reporter mRNA and endogenous murine desmin mRNA (see Materials and
methods). Average HBB mRNA levels were calculated as a percentage of
murine desmin on a transgene copy number basis as in the case of the 22DES
and 4.6DES mice (Fig. 1B). Numbers in parentheses denote transgene copy
number. The results from the smooth muscle uterine and bladder, skeletal leg
muscle, and heart muscle are shown. No expression was detected in nonmuscle
tissues (data not shown). Reproducible, physiological levels of expression per
transgene copy are seen in all muscle cell types.
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no HBB reporter transcripts were detected in nonmuscle tissues
in this experiment (data not shown). However, to confirm that
the 5′ DES region in 18.6DESβ could drive expression in
vascular smooth muscle as well as smooth muscle organs
(uterus, bladder), the S1-nuclease protection assay was repeated
with larger (20–30 μg) amounts of RNA from the low 3-copy
lines B5 and C1 and the high 11-copy line A4. Clear signals of
both the endogenous murine Des and the HBB transgene
transcripts were observed in the highly vascularized spleen,
kidney, liver, and lung tissues that were analyzed, the ratio of
which was comparable to that seen in uterus and bladder (data
not shown).
As 18.6DESβ gave a reproducible pattern of expression that
was very similar to that obtained with the equivalent nativeDES
construct (22DES; Fig. 1B, left), these data imply that the 5′
region extending to −18.6 kb from the transcriptional start site is
sufficient to drive physiological, pan-muscle-specific expres-
sion of DES and that no crucial genetic regulatory elements are
present either within or downstream of the gene.
Discussion
We present here the first report describing the localization
and characterization of a muscle-specific LCR. We originallyshowed that this transcriptional control element is present on a
240-kb PAC clone (240DES) spanning DES [20] and now show
that it consists of five regions of muscle-specific DNase I
hypersensitivity located between −9 and −18 kb 5′ of the
transcriptional start site (Figs. 2–5). The DES LCR can
reproducibly drive full physiological levels of DES expression
in all muscle cell types in transgenic mice (Figs. 1 and 7), which
makes it functionally unique among muscle-specific transcrip-
tional regulatory elements described to date.
The 22DES cosmid clone gave levels of expression that were
greater than 100% per transgene copy, especially in the cardiac
compartment (Fig. 1B). This is similar to the results we obtained
with the much larger 240DES PAC clone [20]. A feature that the
genomic regions contained in 240DES and 22DES have in
common is they lack the downstream SPEG/APEG1 transcrip-
tion unit (Fig. 3A). If the DES LCR regulates the muscle-
specific expression pattern of all three genes within this cluster,
then the downstream SPEG and APEG1 gene promoters could
compete with DES for LCR-mediated activation in striated and
smooth muscle cell types, respectively. In support of this
possibility is the finding that DES-SPEG and DES-APEG1 are
co-expressed within the same muscle cells [30]. This situation
would be analogous to the polar, unidirectional competition
observed between the LCR and the globin genes during
development within the human HBB and mouse Hbb loci [3].
In the absence of competition from SPEG and APEG1,
expression of DES in the 240DES and 22DES transgenes
could therefore be elevated above normal physiological levels
(Fig. 1B). This would be equivalent to the increased levels of
murine Hbb2 expression that are observed after deletion of the
competing upstream Hbb1 gene [41] and the embryonic rather
than adult stage expression ofHBBwhen it is placed in the more
LCR-proximal position normally occupied by HBE1 [4].
In addition, our results show that expression of DES from
either the 240DES [20] or the 22DES (Fig. 1B, left) transgene is
consistently higher per transgene copy in cardiac tissue
compared to smooth or skeletal muscle. There are a number
of reasons this can be the case. First, this may be an artifact of
expressing a human gene in a murine background. Second, it is
possible the higher level of DES transgene expression in the
heart may reflect a true physiological condition; that is, DES
expression is proportionally higher in cardiac than in skeletal or
smooth muscle in humans. Interestingly, DES expression from
the 4.6DES transgene is also reproducibly higher in the heart
than in either skeletal or smooth muscles (Fig. 1B, right),
suggesting that a cardiac-specific enhancer element may reside
within 4.6 kb of the DES transcriptional start site.
Unfortunately, analysis of cells from all of our mouse lines
(Figs. 1 and 7) by double-fluorescence in situ hybridization
using transgene and γ-satellite repeat-specific probes [5] (see
Materials and methods) showed that none possessed a
centromeric transgene integration event (data not shown) that
would have constituted a clear test for the presence of a
dominant chromatin-opening activity [6]. Nevertheless, the
reproducible, physiological level of expression per transgene
copy, especially at low two to three transgene copy numbers, in
all muscle cell types that we observed with 22DES (Fig. 1B,
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region possesses a dominant transcriptional activating capabil-
ity and therefore an LCR function. It is also evident that despite
the clear trend toward transgene copy number-dependent
expression for both the 22DES and the 18.6DESβ transgenes,
there is a small (two- to threefold) variation in the level of
expression per transgene copy in a given tissue type between
different mouse lines, albeit within a physiological range and
similar to what is observed with other LCR-type elements [4].
This degree of variability in expression of 22DES and
18.6DESβ is far lower than that observed with transgenes
driven only by classical promoter and enhancer elements
[42,43]. Transgenes of this type are markedly prone to position
effects and typically give low and highly variable levels of
expression (varying over several orders of magnitude) that are
not proportional to transgene copy number [42,43].
Our data using a cosmid clone encompassing DES with
4.57 kb of 5′ flanking sequences (4.6DES; Fig. 1A) also
showed that this was sufficient to drive expression in all muscle
cell types (Fig. 1B). This is similar to the results obtained using
the equivalent 5′ region from murine Des to drive a lacZ
reporter gene in mice [38]. However, in comparison to 22DES
(Fig. 1B, left), which possesses full DES LCR activity, the level
of expression obtained with 4.6DES was markedly lower, being
on average approximately 30-fold less in the smooth (bladder/
uterine) and 10-fold down in the cardiac and skeletal muscle
compartments (Fig. 1B, right).
Although there have been previous reports of regions
possessing muscle-specific LCR-like activity linked with the
5′-flanking region of the murine βmyosin heavy chain [44] and
the muscle promoter of the human [45] and rat [46] aldolase A
gene, neither produces full levels of gene expression nor do they
function at low transgene copy number, suggesting the lack of
complete LCR function. The reproducible, full physiological
expression pattern demonstrated by the DES 5′ flanking region
described in this report, therefore, constitutes the first detailed
description of an LCR capable of functioning in all muscle cell
types.
At present the genome database shows a transcription unit of
57 kb in mouse and 23.2 kb in human immediately downstream
of the desmin gene designated as aortic preferentially expressed
gene 1 (APEG1 and Apeg1, respectively, in human and mouse;
e.g., see http://www.ensembl.org/). However, it has been shown
that the transcription unit within this region, which possesses an
authentic aortic smooth muscle preferential expression pattern,
is a small (4.5 kb) gene, giving rise to a 1.8-kb transcript [28]. It
was subsequently shown that this 4.5 kb gene was contained
within a larger transcription unit from which are produced a
number of related serine/threonine protein kinases but with a
markedly different tissue expression pattern compared to that of
Apeg1, namely, striated muscle preferentially expressed pro-
teins α and β (SPEGα and SPEGβ) as well as a brain isoform
(BPEG) [30]. In addition, comparative analysis of human and
mouse sequences (Fig. 3B; data not shown) indicate that the
region corresponding to the 4.5-kb Apeg1 gene in humans is
5.5 kb in length and again resides within the much larger SPEG-
encoding transcription unit (Fig. 3B). These previous studiesshowed that Apeg1, SPEGα/β, and BPEG transcripts have a
number of exons in common and may therefore be considered
as isoforms from the same overall transcription unit [30].
However, murine SPEGβ is a 10.8-kb transcript that is
produced from an independent promoter 5′ of the Apeg1 Cap
site, with the Apeg1 promoter residing within a SPEGβ intron.
In addition, SPEGβ possesses extensive 3′ sequences that are
lacking in Apeg1. SPEGα appears to share the first four exons
with Apeg1 but possesses the same large 3′ region as that of
SPEGβ, giving rise to an 8.4-kb mRNA. Furthermore, little or
no Apeg1 is expressed in striated skeletal/cardiac muscle and
very low levels of SPEGα/β are detected in aortic (smooth)
muscle [30].
Our sequence analysis demonstrates that humans and rodents
as well as other mammalian species are highly homologous with
respect to gene organization at the DES locus, including the
position of APEG1 (Fig. 3B; data not shown). Northern blotting
of muscle-tissue mRNA (Fig. 4) in combination with sequence
analysis (Fig. 3B and Supplementary Fig. 1; data not shown)
has confirmed that 11- and 5-kb transcripts that include exon
sequences lying approximately 8 kb downstream of DES are
generated and preferentially expressed in striated (skeletal and
cardiac) muscle (Accession No. DQ395348; Fig. 4). This
contrasts with the current placement of the start of “APEG1” in
the genome database, which is indicated as 16.9 kb 3′ of DES
(see http://www.ensembl.org/). This is due to the fact that the
first exon of the transcription unit downstream ofDES predicted
by our data (Accession No. DQ395348; see Supplementary Fig.
1 and Fig. 4) is at present not included. Comparison with the
equivalent situation in the mouse [30] suggests that the 11-kb
mRNA we detect (Fig. 4) would appear to correspond to the
transcript encoding SPEGβ [30]. The prominent 5-kb transcript
that we also detect (Fig. 4) does not correspond in size to any of
those shown to be present in the mouse [30] and may therefore
represent a human-specific isoform.
In addition, our sequence analysis (Fig. 3B; data not shown)
also suggests that the three-exon, Ensembl-predicted 1.5-kb
gene fragment (ENSG00000144585) shown to lie between
APEG1 and GMPPA (see http://www.ensembl.org/) is, by
homology to the mouse, part of the transcripts encoding
SPEGα and SPEGβ [30]. This is supported by our observation
that combining the novel first exon and the exon sequences of
ENSG00000144585 with the partial SPEG cDNA sequence
already present in the database (AY603755) results in a
predicted transcript of 10,209 bp (Supplementary Fig. 1),
which approximates in size SPEGβ (Fig. 4) [30].
In summary, from the perspective of gene and corresponding
protein function it would appear to be inaccurate to designate
the entire transcription unit 3′ of DES/Des as “APEG1/Apeg1.”
The data presented in this report will therefore allow a
significant update of the genome database with respect to the
annotation of APEG1/Apeg1 so that it accurately reflects both
gene structure and protein function.
Bioinformatics analysis showed that the 5′ DNase I HS site
regions that constitute the DES LCR are highly conserved in
their location and number between human and other mamma-
lian species (Fig. 3B). A detailed comparative DNA sequence
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411 bp and distributed between −9 and −18 kb to be highly (83–
100%) conserved between human and rodent (mouse, rat)
species and to coincide with the muscle-specific DES LCR HS
sites (Figs. 5 and 6). This high degree of species conservation of
these elements further underscores their functional significance.
With the exception of HS3a and HS4c, which lack any predicted
factor binding sites, each of the regions of human–rodent
homology shows a unique set and pattern of potential muscle-
specific and ubiquitous transcription factor binding elements
(see Supplementary Fig. 3) [39] that is consistent with their
potent ability to drive a dominant pan-muscle-specific gene
expression (Figs. 1 and 7). In addition, the fact that the only
transcription factor binding sites that are conserved between
humans and the opossum are those within HS3b and HS3c
(Supplementary Fig. 2) suggests that these two elements may be
particularly important for DES LCR function. It is also evident
that there are a number of regions that reside 3′ ofDES and 5′ of
SPEG that are conserved between human and mammalian
species (but not the opossum). The functional significance (if
any) of these regions of homology within a transcriptional
regulatory context is currently unknown but these elements
appear not to be crucial for DES LCR activity since
reproducible, physiological levels of muscle-specific gene
expression can be obtained in their absence (Fig. 7) [20].
The presence of two muscle preferentially expressed genes
downstream of DES (Fig. 3A) also raises the possibility that the
DES LCR is an integral and important component of a
functional expression module [3] that may regulate and
coordinate transcription of not only DES but also SPEG and
APEG1. This multiple cell and, possibly, gene specificity
associated with the DES LCR is a feature shared by other
elements of this type such as those from the human GH1–
CSHL1 cluster, which shows a dual pituitary and placental
specificity [11], and the murine Tcra/Tcrd–Dad1 locus, which
appears to possess both a T-cell-specific and ubiquitous
function [18]. DES LCR-mediated gene expression of DES
and possibly SPEG and APEG1 may take place via a DNA/
chromatin looping mechanism and formation of an ACH as has
been found for the equivalent element within the murine Hbb
and human HBB loci [3,47]. Alternatively, a “facilitated
tracking” mechanism, as has been proposed to mediate the
function of the human hepatocyte nuclear factor-4α gene
(HNF4A) upstream enhancer [48], may be in operation in this
context. In either of these scenarios it would be necessary for
different components of the DES LCR to function in different
cell types to bring about the correct pattern of muscle-specific
expression of DES and possibly SPEG and APEG1. In addition,
our data to date do not provide insight as to whether the DES
LCR can function as an independent tissue-specific transcrip-
tional regulatory element that is capable of fully activating at
least some heterologous promoters as has been found with the
equivalent elements from the human HBB ([49–51]; M.
Antoniou and F. Grosveld, unpublished results) and CD2 [52]
genes. Future work is aimed at testing these and other
mechanistic models to elucidate the precise nature of DES
LCR-mediated gene function.Overall, the DES LCR would appear to be a highly complex
element, which in all probability functions by cooperation
between its various components [2–4] to fulfill the need to
regulate DES expression both spatially and temporally in all
muscle cell types during development and adult life [20]. In
addition, the structure and function of the DES LCR may
represent a class of transcriptional regulatory elements that
generally direct a developmentally multifaceted spatiotemporal
muscle-specific gene expression program, further exemplified
by the −48- to −58-kb region within the murine Mrf4–Myf5
locus [53].
Finally, given that the defining characteristic of LCRs is their
ability to overcome chromatin position effects and to provide
reproducible, high levels of expression, the inclusion of these
elements in integrating (retroviral and lentiviral) vectors can
greatly assist in overcoming these problems within a gene
therapy context as has been found with the use of the human
HBB [54] and CD2 [55] elements. In addition, we have also
shown using human HBB as a model system that LCR elements
are required to maintain gene expression from replicating
episomal vectors [23]. Our data show that the DES LCR is
capable of driving high, reproducible levels of muscle-specific
expression of a heterologous gene (Fig. 6). This raises the
possibility that efficient DES LCR-based vectors could be
developed for targeting gene expression to any desired muscle
cell type for a wide range of applications, including gene
therapy for the muscular dystrophies, the systemic release of a
therapeutic protein, and DNA vaccines.
Materials and methods
Cosmid genomic clones and plasmid test gene constructs
Genomic clones spanning the human desmin gene (DES) were isolated using
standard procedures from a genomic library (provided by Professor Frank
Grosveld) in the cosmid vector pTCF [56]. Nitrocellulose filters, on which the
library was spread, were hybridized with an 810-bp XhoI–KpnI fragment
extending from −1700 to −890 bp from the DES transcriptional start site. The
extent of the two clones isolated was precisely determined by sequencing and
comparison to the human genome database (see Bioinformatics analysis section
below). These two clones contained an intact DES gene and were found to be
35.76 and 39.92 kb in size. The 39.92-kb clone possesses 22.33-kb 5′ and 9.25-
kb 3′ flanking regions and was therefore designated as 22DES. The 35.76-kb
clone was found to have 4.57 kb of 5′ flanking and 22.85 kb 3′ sequences and
was designated as 4.6DES.
The 18.6DESβ construct, which consisted of the DES 5′ region extending
from −18.6 kb to +30 bp from the transcriptional start site linked to a human β-
globin (HBB) reporter gene was constructed as follows: a 2449-bp SacI fragment
spanning the DES Cap site between −2275 and +174 bp was subcloned into the
SacI site of pBluescript (Stratagene Europe, Amsterdam, The Netherlands). This
was then linearized with SacII, which cuts at the 3′ end of the DES promoter
region insert, and subjected to partial digestion with Bal31. Digested ends were
then blunted through reaction with T4 DNA polymerase, and desmin gene
inserts extending to −1.7 kb from the Cap site were excised from the pBluescript
vector by digestion with XhoI, isolated by gel electrophoresis, and recloned
between the XhoI and the EcoRV sites of pBluescript. A clone that had been
deleted to a position +30 bp from theDES transcriptional start site (and therefore
missing the ATG translation start codon, which is 50 bp downstream from this
point) was then selected and confirmed by DNA sequencing and designated
1.7DES. A 3265-bp HBB subclone extending from a linker-generated XbaI site
at +20 to a native XbaI site at +3285 bp (1679 bp after the polyadenylation site)
was then linked to 1.7DES at its +30 position by insertion into the XbaI site
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flanking DES sequences of 1.7DESβ were then extended by insertion of a 16.9-
kb XhoI fragment from −1.7 to −18.6 kb 5′ of DES, by insertion into the
pBluescript polylinker SalI site, to give the construct 18.6DESβ.
Generation of transgenic mice
DNA fragments for microinjection to generate transgenic mice from the
22DES and 4.6DES cosmid genomic clones were excised by digestion with
NruI, which cuts within the pTCF vector backbone either side of the BamHI
genomic DNA insert cloning site [56]. The 18.6DESβ construct was separated
from pBluescript by digestion with XhoI and NotI, which cut within the vector
polylinker at the 5′ and 3′ ends of the insert, respectively. Genomic insert was
isolated from vector sequences by ultracentrifugation fractionation through
NaCl gradients and used to generate transgenic mice by standard procedures as
previously described [57]. Transgene copy number and integrity was determined
by Southern blot analysis as previously described [20].
Determining the site of transgene integration in mice
Fibroblast cells from transgenic mice were propagated from ear biopsies in
medium consisting of DMEM (Invitrogen Ltd., Paisley, UK) supplemented with
4500 mg/L L-ananyl-L-glutamine, 4.5 μg/μl glucose, 10 μg/ml each penicillin
and streptomycin, and 20% (v/v) heat-inactivated fetal calf serum (PAA
Laboratories, Linz, Austria). These cells were then subjected to double-
fluorescence in situ hybridization using transgene and γ-satellite repeat-specific
probes as previously described [5], to assess if any integration events had taken
place within a centromeric region of a mouse chromosome.
DNase I hypersensitive site analysis
Pure skeletal myoblasts from transgenic mice carrying a single copy of a
fully functional 240-kb PAC clone (240DES) spanning the DES locus [20] were
used as the starting material for this analysis and were produced as follows. The
240DES transgenic mouse line DN28 [20] was bred to homozygosity and
crossed to homozygous ImmortoMouse animals [21]. Clones of skeletal muscle
myoblasts from the resultant double transgenic line were then isolated,
maintained, and induced to undergo terminal differentiation to fused myotubes
as previously described [22]. Nuclei isolated from fused myotube cultures were
then isolated and subjected to DNase I HS site mapping as before [23,24].
Genomic DNA from the DNase I-treated nuclei was digested with XhoI and
analyzed by Southern blotting. The presence of DNase I HS sites was assessed
within a 16.9-kb region extending from −1.7 to −18.6 kb from the DES
transcriptional start site. Blots were sequentially probed with a 5′ 626-bp XhoI–
SacI fragment (position −18.6 to −17.974 kb) and a 3′ 940-bp PstI fragment
(position −2163 to −3103 bp). The same procedure was applied to nuclei
isolated from the human myelogenous leukemia cell line K562 [26], which acted
as a nonmuscle negative control.
Analysis of transgene expression in mice
Total RNA from muscle and nonmuscle mouse tissues was prepared using
TRIzol Reagent (Invitrogen Ltd.) in accordance with the manufacturer's
instructions. Analysis of 22DES and 4.6DES transgene expression by an S1-
nuclease protection assay using an end-labeled DNA probe was as previously
described [20]. Expression analysis of the 18.6DESβ transgene was also by an
S1-nuclease protection assay using a 3′ EcoRI–PstI HBB probe [40]. All
samples were double probed for endogenous murine desmin mRNA and results
expressed as a percentage of murine desmin on a transgene copy number basis
[20]. Results were quantified by phosphorimager analysis using a Typhoon 9200
instrument (Amersham Biosciences UK Ltd., Chalfont St. Giles, Buckingham-
shire, UK).
Bioinformatics analysis of the DES locus
BLAST (http://www.ncbi.nlm.nih.gov/BLAST/) searches using human
desmin cDNA sequences (BC32116) identified a 183,625-bp BAC clone,AC053503, which contained the complete DES gene. The organization of the
DES locus, that is, gene order and direction of transcription, was ascertained
using the NIX program of the former UK Medical Research Council HGMP
facilities, the Human Genome Browser (http://genome.ucsc.edu/cgi-bin/
hgGateway), NCBI Map Viewer (http://www.ncbi.nlm.nih.gov/mapview/),
Ensembl Genome Browser (http://www.ensembl.org/), and former Celera pub-
lic databases. BLAST analysis using appropriate cDNA sequences of mouse
(BC031760) and rat (BC061872) desmin identified BAC clones AC114651
(172,694 bp) and AC121633 (266,167 bp) that spanned the mouse and rat Des
loci, respectively. NCBI Map Viewer, Human Genome Browser, and Ensembl
Genome Browser were used to confirm gene order and direction of tran-
scription at these rodent Des loci. ECR Browser [32] (http://ecrbrowser.dcode.
org/) was used to conduct a multiple vertebrate comparative genome analysis
between human and mouse, rat, canine, opossum, chicken, and various fish
(tetraodon, Fugu, zebrafish) species. Sliding windows of 30 bp throughout the
alignment with a minimum identity of 80% were the parameters employed.
Identification of regions of homology between the human DES 5′ flanking
region and the equivalent area from mouse and rat was determined using a
number of sequence comparison programs. The region starting from within
exon I and extending for 20 kb 5′ of the desmin gene transcriptional start site
was obtained from the human (AC053503), mouse (AC114651), and rat
(AC121633) BAC clones and initially scrutinized for areas of homology by
dot-plot analysis using the Jemboss software package, which was available
from the former HGMP. This was followed by analysis employing the
mVISTA program (http://www-gsd.lbl.gov/vista/) with a window size set at
50 bp and a high homology threshold of 75%. The precise location of regions
of human–rodent homology was identified by DNA sequence comparison of
the same 20-kb upstream regions employing BLAST (http://www.ncbi.nlm.
nih.gov/BLAST/) followed by CLUSTALW (http://www.ebi.ac.uk/clustalw/)
to obtain a multisequence alignment.
Putative transcription factor binding sites within the 5′ DES regions of
human–rodent homology were identified using a range of prediction programs.
The option allowing analysis of orthologous pairs of sequences within ConSite
(http://www.phylofoot.org/; http://mordor.cgb.ki.se/cgi-bin/CONSITE/consite)
was used to scrutinize aligned human and mouse regions of homology. This
was chosen so that only those potential transcription factor binding sites that are
conserved between human and rodent species would be highlighted. The
presence of AP-1 and GATA-4 binding sites was assessed using PATCH (http://
www.gene-regulation.com/cgi-bin/pub/programs/patch/bin/patch.cgi). All tran-
scription factor binding sites indicated were confirmed against the databases
held in ConSite, PATCH, TFSEARCH (http://www.cbrc.jp/research/db/
TFSEARCH.html), and rVista (http://www-gsd.lbl.gov/vista/rDetails.html).
Human muscle multiple-tissue Northern blot analysis
A human multiple-tissue Northern blot containing poly(A)+ RNA from
skeletal muscle, uterus, colon, small intestine, bladder, heart, stomach, and
prostate tissues was hybridized using standard conditions in accordance with the
manufacturer's instructions (BD Biosciences Clontech, Palo Alto, CA, USA).
The hybridization probe was generated by PCR amplification using forward
primer 5′-CCAGCTCTCAGTGGCCATGCAGA-3′, reverse primer 5′-
ACCTCCAGCACTGTGAGCACCG-3′, and cosmid clone 4.6DES as the
DNA template. Standard PCR conditions with an annealing temperature of
60.5°C were employed. The amplification product is 400 bp in size and
corresponds to a region extending from −47 bp to the end of the predicted first
exon of SPEGβ mRNA (see Supplementary Fig. 1), which resides 8241–8641
bp 3′ of DES (Fig. 3A) and is located at position 92,766–93,166 on BAC clone
AC053503.Acknowledgments
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